Final up to date: October 13, 2026
Why are hashish listings so related in 2026?
On April 22, 2026, US Appearing Lawyer Normal Todd Blanche signed an order transferring hashish below a state medical licence and any FDA-approved hashish medication to Schedule III, formally recognising its medical worth and unlocking DEA registration for business operators for the primary time.
Whereas medical hashish remained in Schedule I of the Managed Substances Act (CSA), an organization whose major enterprise is rising and promoting hashish couldn’t precisely state that it complied with federal legislation and thus couldn’t meet the itemizing necessities for each NYSE and NASDAQ.
As such, till this transformation, hashish operators have been successfully locked out of main US exchanges as a result of federal illegality of hashish. For the primary time within the business’s historical past, US hashish operators had a path to listing their shares on blue-chip exchanges.
Crucially, adult-use hashish stays below Schedule I, which means solely operators keen to bifurcate their operations, wall off their medical enterprise, and register their medical amenities with the DEA have a path to the general public markets.
The broader rescheduling course of is unfinished. The DEA’s administrative listening to on the broader rule ran from June 29 to July 14. On September 29, Chief ALJ Derek Julius stayed proceedings pending briefing on a GAO report on the DEA’s scheduling procedures (GAO-26-108623, revealed September 23), and the DEA’s response is due October 13.
What are traders saying?
In ATB Cormark Capital Markets’ newest Hashish Investor Sentiment Survey, carried out from September 21 to 29, respondents put the chance of broader sector uplistings to the NYSE or NASDAQ inside six months at 67%.
That’s the first time uplistings have crossed 50% within the survey’s seven editions. The determine was 23% in spring and 16% a yr in the past. ATB places the soar all the way down to the Trulieve and Glass Home listings, which gave traders confidence that rescheduling might unlock wider change entry.
Listings additionally matter as a result of traders say they’d change what they do with their cash. Requested what would make them put extra capital into US operators, 81.3% named full rescheduling and 37.5% named uplistings to the NYSE or NASDAQ, the second most-cited issue.
The survey closed the day earlier than the Chief Administrative Regulation Decide stayed the rescheduling course of, so ATB concedes its numbers are in all probability now too excessive. It has pushed its base case for full rescheduling to the primary quarter of 2027, and it expects a wave of uplistings after rescheduling moderately than earlier than.
Respondents assigned a 65% chance to full rescheduling to Schedule III inside six months, whereas 70.6% anticipated rescheduling to be accomplished forward of the US midterm elections. Solely 29.4% had raised their publicity to US operators up to now six months, and 64.7% had made no change.
Who has listed since rescheduling?
Trulieve Hashish Corp (TRLV) grew to become the primary US ‘plant touching’ hashish firm to listing on the New York Inventory Trade on June 10, 2026, after separating out its medical arm. It opened at $11.50 and had slipped to $10.75 on the time of publication.
Glass Home Manufacturers (GLAS) adopted weeks later, after executing a near-identical separation of its medical and leisure arms. The California cultivator mentioned on June 25 that its subordinate voting shares have been permitted for the NYSE below GLAS, and buying and selling started on June 30, when the inventory reached a excessive of $13.25. It closed at $4.26 on October 09, about 68% beneath that prime.
Which hashish corporations are presently listed on NASDAQ and NYSE?
No less than 12 hashish operators and producers commerce on the NYSE or NASDAQ as of October 2026. Trulieve and Glass Home Manufacturers are on the NYSE, and ten extra are on NASDAQ, led by Tilray, Cronos and Cover Development. Ancillary corporations, lenders and cannabinoid drug builders additionally listing there.
The NYSE has solely been open to US hashish operators since June. In the meantime the NASDAQ is already house to a broad collection of corporations who have been capable of listing because of being based mostly outdoors of the US and due to this fact not ‘touching’ US hashish.
Operators and producers
| Firm | Ticker | Trade | Notice |
| Trulieve | TRLV | NYSE | First US hashish firm to listing on the NYSE, June 10, 2026 |
| Glass Home Manufacturers | GLAS | NYSE | Buying and selling from June 30, 2026 |
| Cronos Group | CRON | NASDAQ | |
| Tilray Manufacturers | TLRY | NASDAQ | |
| Cover Development | CGC | NASDAQ | |
| Aurora Hashish | ACB | NASDAQ | Previously on the NYSE |
| SNDL | SNDL | NASDAQ | |
| Organigram | OGI | NASDAQ | |
| Village Farms Worldwide | VFF | NASDAQ | |
| Excessive Tide | HITI | NASDAQ | |
| Akanda | AKAN | NASDAQ | Micro-cap |
| IM Hashish | IMCC | NASDAQ | Micro-cap |
Ancillary, retail and expertise
| Firm | Ticker | Trade |
| GrowGeneration | GRWG | NASDAQ |
| Hydrofarm | HYFM | NASDAQ |
| Agrify | AGFY | NASDAQ |
| Forian | FORA | NASDAQ |
| WM Know-how (Weedmaps) | MAPS | NASDAQ |
| Scotts Miracle-Gro | SMG | NASDAQ |
| Turning Level Manufacturers | TPB | NASDAQ |
Cannabinoid pharma and biotech
| Firm | Ticker | Trade |
| Jazz Prescribed drugs | JAZZ | NASDAQ |
| twenty second Century Group | XXII | NASDAQ |
Which hashish corporations are subsequent to uplist?
Curaleaf introduced on Could 26 {that a} 1-for-3 reverse break up would put together it to uplist if regulatory developments enable, taking its subordinate voting shares from 698,728,008 to about 232.9 million. The break up took impact on June 05. Its shares presently commerce on the TSX (CURA) and OTCQX (CURLF).
TerrAscend held a particular assembly on August 24, the place shareholders permitted a share consolidation, with 99.25% of votes solid in favour. The board can set a ratio of between 1-for-5 and 1-for-20, and has till August 24, 2027 to take action. Govt Chairman Jason Wild mentioned in June: “We imagine uplisting to a serious US change is now not a query of if, it’s a query of when.” The corporate has mentioned it has been consulting the US exchanges. It has named neither an change nor a date.
Ascend Wellness held its vote on August 28, the place stockholders permitted a reverse break up by 112,305,378 votes to 1,391,090. The board can set a ratio of between 1-for-10 and 1-for-50, and it should take impact earlier than any nationwide change itemizing or inside a yr of the assembly, whichever comes first. Ascend’s proxy assertion says it intends to use to listing on the NYSE American or NASDAQ.
Verano Holdings. Verano accomplished a 1-for-5 share consolidation on June 11, 2026, after saying it on June 01. It trades on CBOE Canada and OTCQX below VRNO. The corporate redomiciled from British Columbia to Nevada in November 2025. It has not but named a US change or filed an inventory utility.
Vireo Development. Vireo accomplished a 30-for-1 share consolidation on June 05, 2026. It trades on the CSE (VREO) and OTCQX (VREOF). The corporate has not but publicly mentioned it plans to listing within the US, though CB1 Capital’s Todd Harrison has named it among the many operators greatest positioned to observe Trulieve and Glass Home.
Jushi Holdings. Shareholders permitted Jushi’s transfer from British Columbia to Nevada on June 24, and it accomplished on July 30, 2026. Jushi trades on the CSE (JUSH) and OTCQX. It has made no assertion a few US change itemizing.
Cresco Labs. Cresco mentioned in June that it was ‘actively making ready for a possible uplisting’. Its Administration Data Round, revealed September 25, units an October 30 shareholder assembly. It refers to a ‘potential itemizing on a senior US change’ and describes a brand new holding firm redomiciled to Delaware. No change is called.
Veri Medtech. Veri Medtech (VRHI) has set phrases for a $15 million providing of three.75 million shares at $4.00 and says it intends to uplist from OTCID to NASDAQ.
Why do hashish corporations have to reverse break up?
Hashish corporations use reverse splits to satisfy US change value guidelines, each to get listed and to remain listed. The principle boards ask for a $4 share value to listing, whereas Nasdaq requires a $1 bid and the NYSE a $1 common shut to remain listed. Consolidating shares lifts the worth with out altering the corporate’s worth.
To listing
The NYSE’s Preliminary itemizing requirements require a $4.00 share value in every class. Underneath its market capitalisation take a look at, the closing value should be $4.00 or extra for a minimum of 90 consecutive buying and selling days. NYSE American, the smaller board, moved to a flat $4 requirement in rule modifications the SEC permitted on March 27, 2026.
SImilarly, the NASDAQ’s World Market guidelines require a minimal bid value of a minimum of $4 per share.
Most multistate operators commerce nicely beneath that on the OTC markets, so that they consolidate first. Curaleaf went 1-for-3 and Verano 1-for-5. Ascend Wellness has approval for any ratio from 1-for-10 to 1-for-50, and TerrAscend from 1-for-5 to 1-for-20.
To remain listed
NASDAQ’s continued itemizing guidelines require a minimal bid value of $1 per share. A inventory that closes beneath $1 for 30 consecutive enterprise days attracts a deficiency discover and, usually, 180 days to shut at $1 or extra for 10 consecutive enterprise days. Capital Market corporations can generally get a second 180-day interval.
IM Hashish, for instance, introduced on April 10, 2026 that it had obtained a bid value deficiency discover and had till October 06, 2026 to treatment it. A reverse break up is the same old repair. The NYSE has an analogous rule. A median closing value beneath $1.00 over 30 buying and selling days places an organization out of compliance, with six months to rectify.
The foundations are tighter for repeat consolidators. NADSAQ offers no compliance interval to an organization that carried out a reverse break up within the prior yr, or splits totalling 250-to-1 or extra in two years, and may transfer straight to delisting. The identical applies if the inventory closes at $0.10 or much less for 10 consecutive enterprise days.
The businesses additionally say a better value widens their investor base. TerrAscend’s proxy says some institutional traders have inner insurance policies that prohibit or discourage them from shopping for shares beneath a sure value. Ascend says the break up might enhance visibility with analysts and broker-dealers and assist institutional participation. Each are the businesses’ personal claims, and each say a better value might not maintain after the break up.
FAQ
Is Trulieve listed on the NYSE? Sure. Trulieve started buying and selling on the NYSE below TRLV on June 10, 2026, the primary US hashish firm to listing on a serious US change.
Has Curaleaf listed on the NYSE or NASDAQ? No. Curaleaf accomplished a 1-for-3 reverse break up in June and says it’s making ready to uplist, nevertheless it had filed no formal utility as of late Could and nonetheless trades on the TSX and OTCQX.
Why are hashish corporations doing reverse inventory splits? To elevate their share costs above the minimal US exchanges require at itemizing, and above ranges that prohibit some retail brokers and institutional traders.
Are hashish shares a very good funding? Enterprise of Hashish doesn’t give funding recommendation. Sector valuations are low, the five-year report is poor, and the tax and rescheduling image is unresolved.
Is hashish authorized within the US now? No, hashish stays federally unlawful. State-licensed medical hashish was moved to Schedule III on April 22, 2026. Grownup-use stays Schedule I, and the broader DEA course of stays incomplete.
